The effect of streptomycin on the ability of Shigella sonnei 3SR and enterotoxigenic Escherichia coli 2SR to associate with cecal tissue of mice in vivo and in vitro was examined. After orogastric challenge, both pathogens associated in significantly greater numbers (P < 0.05) with the cecal tissue of streptomycin-treated mice than with the tissue of untreated mice. The population levels of the pathogens were also significantly greater (P < 0.05) in the cecal contents of streptomycin-treated mice than in untreated mice. When excised cecal tissues from the two groups of mice were exposed to the pathogens in vitro, the extent of the association of the pathogens was markedly greater with tissues from streptomycin-treated mice than with tissues from untreated mice. There was also a positive correlation between the numbers of the pathogens in the suspending fluid and the extent of the tissue associations. The population size of fusiform organisms, which are the major components of the mucus layer of the ceca of mice, was reduced 100-fold by streptomycin administration. This was determined by microscopic count. Sections of cecal tissue obtained from the mice and stained with hematoxylin and eosin demonstrated that streptomycin administration greatly decreased the number of fusiform bacteria present in the mucosal microbial layer. We speculate that the partial elimination of fusiform organisms from this layer by streptomycin administration provides available association sites for pathogens so that they can successfully colonize the mouse cecum.
Mucosal attachment is a prerequisite for successful colonization of the gut by both the indigenous microflora and pathogens (2, 11, 14) . The classical enteric pathogens, such as enterotoxigenic Escherichia coli (ETEC), manage to evade removal by the peristaltic activity of the jejunum and ileum by adhering to the mucosa and thus are able to colonize the small intestine (1) . It has been proposed that competition occurs between pathogens and microflora components for adherence sites on intestinal mucosal cells (15) . This theory was developed after it was discovered that indigenous bacteria adhere to specific receptors on these cells. The microflora, firmly attached to the mucosa, prevent the colonization of the area by pathogenic organisms such as Salmonella spp. (15) . The specificity of attachment appears to be greater between host cells and microflora components than between host cells and pathogens (8) . The pathogens can therefore be displaced by microflora components (12) .
Numerous studies have demonstrated that fusiform rods and helical bacteria constitute the major flora components associated with the mucosa of the mouse cecum (5, 7, 12) . Such organisms form thick layers in the mucus on the colonic epithelial surface. In an interesting series of reports, Cohen et al. (3, 4) showed that both ETEC and normal commensal E. coli colonize the mouse intestine by adhering to specific glycoprotein receptors in the intestinal mucus gel.
Results from previous studies in our laboratory (P. Pongpech and D. J. Hentges, Microb. Ecol. Health Dis., in press) demonstrated that oral administration of streptomycin to mice significantly enhanced (P < 0.05) the susceptibility of the animals to colonization with Shigella sonnei 3SR and ETEC 2SR. We also showed that short-chain volatile fatty acids, operating at the pH level of cecal contents of untreated mice, were important determinants of colonization resistance against these pathogens (Pongpech and Hentges, * Corresponding author. in press). However, additional colonization resistance mechanisms may be operable. In the present study, we demonstrate that the enteric pathogens apparently compete with microflora components for association sites on the mucosa of the cecum. Experiments performed both in vitro and in vivo show that S. sonnei 3SR and ETEC 2SR associate to a greater extent with cecal tissues of streptomycin-treated mice than with those of untreated mice. Additionally, we show that streptomycin administration significantly diminishes the populations of fusiform bacteria normally colonizing the mucus layer of the mouse cecum. We speculate that the presence of these organisms represents a deterrent to colonization of epithelial surfaces by the pathogens. MATERIALS 
RESULTS
Association with cecal tissues. The ability of S. sonnei 3SR and ETEC 2SR to associate with cecal tissues of streptomycin-treated mice and untreated control mice in vivo was determined first. The population levels of S. sonnei 3SR associated with cecal tissues were, at all time intervals after challenge, significantly higher (P < 0.05) in streptomycintreated mice than in untreated mice (Fig. 1) . At 48 h after challenge, for example, 1.2 x 107 viable S. sonnei 3SR cells per g were associated with the cecal tissues of streptomycintreated mice, whereas only 1.7 x 101 cells per g were associated with the tissues of untreated mice. Similar results were obtained in experiments with ETEC 2SR (Fig. 2) . At 48 h after challenge, ETEC 2SR was present at levels of 2.2 x 106 viable bacteria per g of cecal tissue from streptomycintreated mice, while significantly lower population levels were found in the cecal tissues from untreated mice (1.3 x 103 viable bacteria per g).
The population levels of S. sonnei 3SR and ETEC 2SR in cecal contents from these mice were also determined. Similar relationships were observed. The population levels of S. sonnei 3SR were significantly greater (P c 0.05) in the cecal contents from streptomycin-treated mice than in the contents from untreated mice (Fig. 3) bacteria per g in the contents from untreated mice were observed (Fig. 4) .
In vitro cecal tissue association. In vitro studies were performed, using excised cecal tissues obtained from streptomycin-treated and untreated mice. The objective was to determine whether the greater degree of association of the pathogens with the cecal tissues of streptomycin-treated mice than with those of untreated mice was due to exposure to larger numbers of organisms in cecal contents or to a modification of the tissues by the antibiotic. The results are expressed as percentages of the total numbers of organisms in the inoculum that were found to associate with the tissues, as described in Materials and Methods. Figures 5 and 6 show that, for a given inoculum, both organisms associated with cecal tissues obtained from streptomycin-treated mice in much larger numbers than with tissues from untreated mice. Additionally, a direct correlation was found between the extent to which the organisms associated with the tissues and the numbers of organisms to which the tissues were exposed. Results obtained with S. sonnei 3SR are illustrated in Fig. 5 sonnei 3SR (Fig. 6) . When tissues were exposed to 7.5 x 109 viable ETEC 2SR, the association indices were determined to be 53.75% in tissues from streptomycin-treated mice and 17.09% in tissues from untreated mice. When tissues were exposed to 1.2 x 108 viable organisms, association indices were 29.67 and 15.4% for streptomycin-treated and untreated mice, respectively. Similarly, when the number of ETEC 2SR was reduced further to 1.5 x 105, association indices of 16.63% in tissues from streptomycin-treated mice and 5.71% in tissues from untreated mice were obtained.
Numbers of fusiform organisms in ceca. This experiment was performed to determine whether streptomycin treatment decreased the number of fusiform organisms, which are the major intestinal flora components of the cecal mucus layer of mice. The number of these organisms was significantly lower (P c 0.01) in the ceca of streptomycin-treated mice after 7 days of treatment than in the ceca of untreated mice. There were 2.57 x 10" fusiform organisms per g of cecum from untreated mice but only 9.77 x 108 organisms per g of cecum from streptomycin-treated mice.
Fusiform organisms associated with the cecal mucosal microbial layer. In untreated control mice, there was a predominance of fusiform organisms in the cecal microbial layer. These organisms were seen as very long, slender, rodshaped forms often in sheaves or parallel arrays (Fig. 7A) . Even though the number of fusiform bacteria in the layer after streptomycin treatment varied among different animals, the number was smaller in treated animals than in untreated animals. In some cases it was markedly smaller (Fig. 7B) . Of the 10 cecal tissue specimens from streptomycin-treated mice, 6 had very few fusiform organisms in the microbial layer, 2 had a moderate number, and 2 had a slight predom- inance of these organisms. The microbial layer of all tissue specimens from untreated mice contained large numbers of fusiform organisms, however. Microorganisms in the layer, in addition to fusiform organisms, consisted of cocci and small rod-shaped forms. There were no apparent morphological differences in the cecal mucosa, submucosa, or muscularis between streptomycin-treated mice and untreated control mice.
DISCUSSION
Occupation, by indigenous intestinal flora components, of mucosal association sites required by enteric pathogens for successful colonization of the intestine is considered to be an important mechanism responsible for colonization resistance (13, 15) . The data presented in this study support this theory. When mice were challenged with either S. sonnei 3SR or ETEC 2SR, the number of pathogens associated with cecal tissues from streptomycin-treated mice was consistently greater than the number of pathogens associated with tissues from untreated mice. Similar relationships were observed in vitro, using excised cecal tissues. When exposed to the same numbers of organisms, cecal tissues obtained from streptomycin-treated mice were consistently associated with far greater numbers of pathogens than were tissues obtained from untreated mice. Additionally, there was a positive correlation between the extent to which both organisms associated with the tissues and the numbers of organisms to which the tissues were exposed. The observed increase in the association by both S. sonnei 3SR and ETEC 2SR with intestinal tissues in vivo following streptomycin treatment was therefore due, in part, to the greater population levels of the pathogens in the cecal contents of the streptomycintreated mice. Figures 1 through 4 show that the populations of both pathogens increased in the cecal contents and tissues of streptomycin-treated mice during the 24-h period after challenge and persisted at high levels for the duration of the experiments. This was not the case with untreated mice. It is apparent, however, that exposure to large numbers of pathogens, although contributing to the effect, cannot in itself account for the increased susceptibility of cecal tissues to colonization with the pathogens after streptomycin treatment. Administration of streptomycin to mice had a much greater impact on the susceptibility of cecal tissues to colonization with the pathogens in vitro than did exposure of the tissues to large numbers of these organisms ( Fig. 5 and   6 ).
Streptomycin treatment markedly decreased, by more than 100-fold, the number of fusiform bacteria present in the mouse cecum. This decrease in number was statistically significant (P < 0.01). Microscopic examination of sections of cecal tissues obtained from both streptomycin-treated and untreated mice confirmed that fusiform organisms which predominated in the mucosal microbial layer of untreated mice were present at greatly reduced populations in the microbial layer of streptomycin-treated animals. Streptomycin treatment strongly affected the integrity of this layer but did not totally eliminate fusiform organisms from the cecum. Curiously, when amoebae were also present in the microbial layer, streptomycin appeared to be less inhibitory for fusiform organisms than when the amoebae were absent. The reason for this apparent protective activity is unknown.
From these results, it appears that a positive correlation exists between the presence of large numbers of fusiform organisms and colonization resistance against S. sonnei 3SR and ETEC 2SR in the ceca of mice. Indeed, Kennedy et al. (10) provided evidence that fusiform organisms contribute to colonization resistance by preventing the association of enteric pathogens with mucosal surfaces. Fusiform organisms form a dense layer of bacteria in the mucus gel, presumably depriving enteric pathogens of adhesion sites. Additionally, Lee and Gemmell (11) demonstrated that fusiform organisms produce volatile fatty acids, especially butyric acid, that inhibit coliform bacteria in the intestinal tract of mice, resulting in a decline in their numbers. Volatile fatty acid production may be the principal mechanism of antagonism by fusiform organisms.
In conclusion, the results of this study and those of our previous studies (Pongpech and Hentges, in press) provide strong evidence that two important colonization resistance mechanisms exist against S. sonnei 3SR and ETEC 2SR in the intestinal tract of conventional mice. They are the combined inhibitory effects of short-chain volatile fatty acids, produced by the flora as metabolic products, and the occupation by flora components of mucosal association sites required by the pathogens for successful colonization. A drastic decrease in the number of fusiform organisms in the mucosa after streptomycin administration is associated with an increase in the colonization of this region by the enteric 
